-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Analyst Expectations for Rain Oncology's Future
Analyst Expectations for Rain Oncology's Future
Within the last quarter, Rain Oncology (NASDAQ:RAIN) has observed the following analyst ratings:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 1 | 3 | 0 | 0 |
Last 30D | 0 | 0 | 3 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 3 | 1 | 0 | 0 | 0 |
In the last 3 months, 8 analysts have offered 12-month price targets for Rain Oncology. The company has an average price target of $10.91 with a high of $19.00 and a low of $1.50.
Below is a summary of how these 8 analysts rated Rain Oncology over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
This current average represents a 35.82% decrease from the previous average price target of $17.00.
Stay up to date on Rain Oncology analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Analyst Ratings: What Are They?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Within the last quarter, Rain Oncology (NASDAQ:RAIN) has observed the following analyst ratings:
在上個季度中,Rain Oncology(納斯達克股票代碼:RAIN)觀察到以下分析師評級:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 1 | 3 | 0 | 0 |
Last 30D | 0 | 0 | 3 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 0 | 0 | 0 | 0 |
3M Ago | 3 | 1 | 0 | 0 | 0 |
看漲 | 有點看漲 | 冷漠 | 有點看跌 | 看跌 | |
---|---|---|---|---|---|
總收視率 | 4 | 1 | 3 | 0 | 0 |
最後 30 天 | 0 | 0 | 3 | 0 | 0 |
1 月前 | 1 | 0 | 0 | 0 | 0 |
2 萬之前 | 0 | 0 | 0 | 0 | 0 |
3 萬之前 | 3 | 1 | 0 | 0 | 0 |
In the last 3 months, 8 analysts have offered 12-month price targets for Rain Oncology. The company has an average price target of $10.91 with a high of $19.00 and a low of $1.50.
在過去的3個月中,有8位分析師爲Rain Oncology提供了12個月的目標股價。該公司的平均目標價爲10.91美元,最高爲19.00美元,低點爲1.50美元。
Below is a summary of how these 8 analysts rated Rain Oncology over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
以下是這8位分析師在過去3個月中對Rain Oncology的評級摘要。看漲評級的數量越多,分析師對該股票的正面評價就越多,看跌評級的數量越多,分析師對該股的負面評價就越多
This current average represents a 35.82% decrease from the previous average price target of $17.00.
目前的平均價格比之前的平均目標價17.00美元下降了35.82%。
Stay up to date on Rain Oncology analyst ratings.
隨時瞭解Rain Oncology分析師評級的最新情況。
If you are interested in following small-cap stock news and performance you can start by tracking it here.
如果你有興趣關注小盤股的新聞和表現,可以先在這裏追蹤。
Analyst Ratings: What Are They?
分析師評級:它們是甚麼?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
分析師是銀行和金融系統中的專家,通常報告特定股票或特定行業的股票。這些人研究公司的財務報表,參加電話會議和會議,並與相關內部人士交談,以確定所謂的股票分析師評級。通常,分析師會每季度對每隻股票進行一次評級。
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
一些分析師還將提供增長預期、收益和收入等指標的預測,以爲股票提供進一步指導。使用分析師評級的投資者應注意,這種專業建議來自人類,可能會出錯。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧